載入...
The use of bevacizumab in refractory ovarian granulosa-cell carcinoma with symptomatic relief of ascites: A case report
BACKGROUND: The potential role of bevacizumab in the treatment of ovarian granulosa-cell tumors has not been evaluated. CASE: An 82 year old woman with refractory ovarian granulosa-cell carcinoma was treated with bevacizumab with symptomatic relief of ascites. CONCLUSION: Bevacizumab may have a role...
Na minha lista:
| 發表在: | Gynecol Oncol |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2008
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5047386/ https://ncbi.nlm.nih.gov/pubmed/18710781 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2008.07.015 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|